Works by Zhang, Xiaosha


Results: 14
    1

    Validation of a patient‐reported outcomes symptom measure for patients with nontransfusion‐dependent thalassemia (NTDT‐PRO<sup>©</sup>).

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 2, p. 177, doi. 10.1002/ajh.25344
    By:
    • Taher, Ali;
    • Cappellini, Maria Domenica;
    • Viprakasit, Vip;
    • Sutcharitchan, Pranee;
    • Mahmoud, Dalia;
    • Laadem, Abderrahmane;
    • Khan, Anzalee;
    • Gwaltney, Chad;
    • Harding, Gale;
    • Attie, Kenneth;
    • Zhang, Xiaosha;
    • Zou, Jun;
    • Pariseau, Joseph;
    • Henry Hu, X.;
    • Kattamis, Antonis
    Publication type:
    Article
    2

    Development of a patient‐reported outcomes symptom measure for patients with nontransfusion‐dependent thalassemia (NTDT‐PRO<sup>©</sup>).

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 2, p. 171, doi. 10.1002/ajh.25343
    By:
    • Taher, Ali;
    • Viprakasit, Vip;
    • Cappellini, Maria Domenica;
    • Sutcharitchan, Pranee;
    • Ward, Richard;
    • Mahmoud, Dalia;
    • Laadem, Abderrahmane;
    • Khan, Anzalee;
    • Gwaltney, Chad;
    • Harding, Gale;
    • Attie, Kenneth;
    • Zhang, Xiaosha;
    • Zou, Jun;
    • Pariseau, Joseph;
    • Hu, X. Henry;
    • Kattamis, Antonis
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma.

    Published in:
    2019
    By:
    • Voss, Martin H.;
    • Bhatt, Rupal S.;
    • Vogelzang, Nicholas J.;
    • Fishman, Mayer;
    • Alter, Robert S.;
    • Rini, Brian I.;
    • Beck, J. Thaddeus;
    • Joshi, Monika;
    • Hauke, Ralph;
    • Atkins, Michael B.;
    • Burgess, Earle;
    • Logan, Theodore F.;
    • Shaffer, David;
    • Parikh, Rahul;
    • Moazzam, Nauman;
    • Zhang, Xiaosha;
    • Glasser, Chad;
    • Sherman, Matthew L.;
    • Plimack, Elizabeth R.
    Publication type:
    journal article
    9
    10
    11
    12
    13
    14